UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.88% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.52% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXJ
3926
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
| $811K | ﹤0.01% |
73,678
-7,396
| -9% | -$92K |
|
3927
CALL
iShares US Home Construction ETF
ITB
$2.37B
| $809K | ﹤0.01% |
15,555
-179,545
| -92% | -$10.3M |
|
3928
CALL
SSR Mining
SSRM
$6.5B
| $809K | ﹤0.01% |
55,000
-32,500
| -37% | -$489K |
|
|
ICPT
3929
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $809K | ﹤0.01% |
58,025
-35,265
| -38% | -$568K |
|
|
FLNA
3930
PUT
Filana Therapeutics
FLNA
$45.9M
| $807K | ﹤0.01% |
19,300
| – | – |
|
3931
Embecta
EMBC
$293M
| $806K | ﹤0.01% |
28,008
-4,122
| -13% | -$122K |
|
3932
PUT
Amcor
AMCR
$21.5B
| $805K | ﹤0.01% |
15,000
-24,120
| -62% | -$1.48M |
|
3933
Camden National
CAC
$991M
| $804K | ﹤0.01% |
18,879
+136
| +0.7% | +$6.18K |
|
3934
Cenovus Energy
CVE
$56.5B
| $804K | ﹤0.01% |
52,324
-123,587
| -70% | -$2.2M |
|
3935
Parsons
PSN
$5.06B
| $804K | ﹤0.01% |
20,507
-7,695
| -27% | -$319K |
|
|
HA
3936
DELISTED
Hawaiian Holdings, Inc.
HA
| $804K | ﹤0.01% |
61,116
+2,052
| +3% | +$31.3K |
|
3937
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $803K | ﹤0.01% |
2,000
| – | – |
|
3938
Braze
BRZE
$3.35B
| $801K | ﹤0.01% |
23,009
-89,064
| -79% | -$3.76M |
|
|
SAGE
3939
DELISTED
Sage Therapeutics
SAGE
| $801K | ﹤0.01% |
20,469
-54,292
| -73% | -$2.1M |
|
3940
America's Car Mart
CRMT
$26.1M
| $800K | ﹤0.01% |
13,109
-308
| -2% | -$27.6K |
|
3941
Forrester Research
FORR
$225M
| $800K | ﹤0.01% |
22,228
+21,822
| +5,375% | +$937K |
|
3942
PUT
Warby Parker
WRBY
$3.2B
| $800K | ﹤0.01% |
+60,000
| New | +$799K |
|
3943
Arcosa
ACA
$7.13B
| $797K | ﹤0.01% |
13,934
+7,594
| +120% | +$421K |
|
3944
Trinity Industries
TRN
$2.33B
| $797K | ﹤0.01% |
37,354
+13,269
| +55% | +$325K |
|
3945
Maximus
MMS
$2.93B
| $796K | ﹤0.01% |
13,751
-22,931
| -63% | -$1.43M |
|
3946
Omnicell
OMCL
$1.72B
| $796K | ﹤0.01% |
9,143
+4,228
| +86% | +$444K |
|
3947
APi Group
APG
$18.7B
| $795K | ﹤0.01% |
89,804
+32,027
| +55% | +$341K |
|
3948
Euronet Worldwide
EEFT
$2.77B
| $794K | ﹤0.01% |
10,477
-290
| -3% | -$27.2K |
|
3949
PUT
Opendoor
OPEN
$3.52B
| $794K | ﹤0.01% |
263,913
+160,580
| +155% | +$737K |
|
3950
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
| $793K | ﹤0.01% |
41,776
+9,330
| +29% | +$188K |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2022 filing shows 1,175 new, 4,825 increased, 3,846 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,175 new positions and closed 1,024 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.